GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OK Biotech Co Ltd (TPE:4155) » Definitions » Deferred Tax

OK Biotech Co (TPE:4155) Deferred Tax : NT$0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is OK Biotech Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

OK Biotech Co's change in deferred tax for the three months ended in Sep. 2024 was NT$0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was NT$0 Mil.

OK Biotech Co Deferred Tax Historical Data

The historical data trend for OK Biotech Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OK Biotech Co Deferred Tax Chart

OK Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OK Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OK Biotech Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of OK Biotech Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

OK Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OK Biotech Co Ltd (TPE:4155) » Definitions » Deferred Tax
Comparable Companies
TPE:6861 ROCO:4138 ROCO:1799 TPE:6796 TPE:4106 ROCO:6815 ROCO:6747 ROCO:4121 ROCO:4745 TPE:6598 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No.91, Gongdao 5th Road, Section 2, Hsinchu, TWN, 30070
Website
https://www.okbiotech.com
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical equipment. The company's products include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others. Geographically, the company generates a majority of its revenue from Asia (excluding Taiwan) followed by America, Africa, Europe, and Taiwan.

OK Biotech Co Headlines

No Headlines